INTRODUCTION {#s1}
============

Although the incidence of gastric cancer has significantly decreased worldwide, it is still the second most common malignancy in China \[[@R1]\]. Thus, identification of its risk factors for prognosis remains greatly important to clinicians. A variety of factors have been adequately analyzed in order to evaluate their predictive value of prognosis for gastric cancer, including tumor diameter \[[@R2]\], T stage \[[@R3]\], N stage \[[@R4]\], tumor markers \[[@R5], [@R6]\] and other novel indexes \[[@R7]--[@R9]\].

Till now, the most commonly used classification is TNM staging system including T stage, N stage and distant metastasis, which was recommended by American Joint Committee on Cancer (AJCC) \[[@R10]\] and Japanese Gastric Cancer Association (JGCA) \[[@R11]\]. However, the tumor diameter, as an important prognostic factor which was demonstrated in many other tumors \[[@R12]--[@R15]\] as well as gastric cancer \[[@R16]\], has not been included in the TNM staging system yet. Thus, in present study, we defined a new index---tumor volume (V) by the formula V = Tumor diameter × (T stage)^2^/2, and investigated the prognostic value of tumor volume and VNM for gastric cancer.

RESULTS {#s2}
=======

General features of gastric cancer patients {#s2_1}
-------------------------------------------

There were 2662 males (78.1%) and 747 females (21.9%). The patient age ranged from 20 to 90 years (median, 58; mean, 57). The follow up time ranged from 1 to 75 months (median, 24.9; mean, 28.1). The 1-, 3- and 5-year overall survival rate was 89.0%, 66.6% and 57.9%, respectively. There were 1705 patients in training set and 1704 patients in validation set. The clinicopathological characteristics were comparable between training and validation set (Table [1](#T1){ref-type="table"}).

###### Clinicopathological characteristics of patients in training and validation set

  Characteristics                    Training set   Validation set   *P* value                                                                   
  ---------------------------------- -------------- ---------------- ----------- ----- ----- ---------- ----- ----- ----- ----- ----- ---------- -------
  Age                                                                                        0.311                                    0.461      0.989
  ≤ 60                               213            110              324         226   139              203   107   321   240   140              
  \> 60                              127            68               214         174   110              124   72    206   183   108              
  Gender                                                                                     0.576                                    0.068      0.051
  Male                               268            149              425         312   201              242   152   403   325   185              
  Female                             72             29               113         88    48               85    27    124   98    63               
  Tumor location                                                                             \< 0.001                                 \< 0.001   0.850
  Upper third                        53             48               195         153   90               61    48    181   159   85               
  Middle third                       58             22               84          58    50               52    27    98    64    41               
  Lower third                        218            96               230         151   67               202   99    222   156   89               
  **Upper-middle or middle-lower**   11             12               29          38    42               12    5     26    44    33               
  Macroscopic type                                                                           \< 0.001                                 \< 0.001   0.387
  Early stage                        309            2                0           0     0                291   1     0     0     0                
  Bormann I                          6              22               50          34    29               7     15    39    36    19               
  Bormann II                         11             119              164         76    44               19    124   173   65    35               
  Bormann III                        1              24               265         212   131              2     25    251   255   137              
  Bormann IV                         2              4                40          56    32               0     9     38    41    50               
  **Differentiation degree**                                                                 \< 0.001                                 \< 0.001   0.736
  **Well differentiated**            101            19               44          20    8                114   14    44    20    4                
  **Moderately differentiated**      90             44               160         86    48               88    68    146   100   37               
  **Poorly differentiated**          136            105              304         264   164              114   92    321   271   185              
  **Mucinous or signet ring cell**   10             9                26          25    28               11    5     16    30    22               
  Tumor diameter\*                                                                           \< 0.001                                 \< 0.001   0.954
  ≤ 2.5 cm                           232            47               52          0     0                230   52    58    0     0                
  2.5--4.3 cm                        96             129              243         79    2                75    126   252   87    2                
  4.3--5.5 cm                        7              0                206         103   4                15    0     186   107   3                
  \> 5.5 cm                          5              2                37          218   243              7     1     31    229   243              
  T stage                                                                                    \< 0.001                                 \< 0.001   0.699
  T1                                 326            2                0           0     0                306   1     0     0     0                
  T2                                 14             169              79          0     0                20    174   78    0     0                
  T3                                 0              6                389         218   14               1     4     395   229   8                
  T4a                                0              1                69          180   220              0     0     53    193   230              
  T4b                                0              0                1           2     15               0     0     1     1     10               
  N stage                                                                                    \< 0.001                                 \< 0.001   0.587
  N0                                 288            86               158         67    22               274   88    155   69    26               
  N1                                 32             40               138         64    24               32    41    146   88    26               
  N2                                 14             25               114         91    61               16    30    105   96    43               
  N3a                                5              24               102         125   82               5     16    92    121   103              
  N3b                                1              3                26          53    60               0     4     29    49    50               
  Vessel invasion                                                                            \< 0.001                                 \< 0.001   0.874
  Positive                           45             65               209         233   187              51    60    214   235   180              
  Negative                           182            58               166         80    40               175   55    139   102   49               
  Neural invasion                                                                            \< 0.001                                 \< 0.001   0.347
  Positive                           62             87               314         278   218              70    75    302   313   215              
  Negative                           128            38               63          37    8                119   39    56    24    16               
  TNM stage                                                                                  \< 0.001                                 \< 0.001   0.239
  IA                                 279            1                0           0     0                260   1     0     0     0                
  IB                                 39             81               29          0     0                41    85    35    0     0                
  IIA                                17             45               140         41    3                20    43    132   42    0                
  IIB                                5              24               140         72    20               4     29    143   71    27               
  IIIA                               0              26               105         65    24               2     21    102   110   27               
  IIIB                               0              1                96          139   64               0     0     98    120   43               
  IIIC                               0              0                28          83    138              0     0     17    80    151              
  VNM stage                                                                                  \< 0.001                                 \< 0.001   0.963
  IA                                 288            0                0           0     0                274   0     0     0     0                
  IB                                 32             86               0           0     0                32    88    0     0     0                
  IIA                                14             40               161         0     0                16    41    166   0     0                
  IIB                                6              25               143         67    0                5     30    139   69    0                
  IIIA                               0              27               107         64    0                0     20    106   88    0                
  IIIB                               0              0                127         91    46               0     0     116   96    52               
  IIIC                               0              0                0           178   203              0     0     0     170   196              

Tumor diameter\*: Tumor diameter was divided into 4 subgroups according to the 3 optimal cutoff points calculated by X-tile software ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}).

Definition of V stage and VNM stage {#s2_2}
-----------------------------------

Tumor volume was calculated by the formula V = Tumor diameter × (T stage)^2^/2 (1 represents T1 stage, 2 represents T2 stage, 3 represents T3 stage, 4 represents T4a stage, and 5 represents T4b stage). The 4 optimal cutoff points of tumor volume (all *P \<* 0.05) in training set were showed in Figure [1](#F1){ref-type="fig"}. Then, V stage was defined according to the 4 cutoff points: V1 (≤ 3.5), V2 (3.5--8.6), V3 (8.6--25.0), V4 (25.0--45.0) and V5 (\> 45.0). VNM system was designed as combination of V stage, N stage and M stage on the basis of 7th edition of AJCC cancer staging manual.

![Calculation of cutoff points of tumor volume by X-tile in training set\
(**A**) Three subgroups were built according to the 2 optimal cutoff points (9.6, 45.0, *P \<* 0.001); (**B**) Two subgroups were built according to the optimal cutoff point (3.5, *P \<* 0.001) for patients with tumor volume between 0 and 9.6. (**C**) Two subgroups were built according to the optimal cutoff point (25.0, *P \<* 0.001) for patients with tumor volume between 9.6 and 45.0. (**D**) No cutoff point was obtained for patients with tumor volume exceed 45.0.](oncotarget-08-18968-g001){#F1}

The correlation between V stage and other factors were analyzed in Table [1](#T1){ref-type="table"}. Both in training and validation set, V stage was found to be significantly associated with tumor location (*P \<* 0.001), macroscopic type (*P \<* 0.001), differentiation degree (*P \<* 0.001), tumor diameter (*P \<* 0.001), T stage (*P \<* 0.001), N stage (*P \<* 0.001), vessel invasion (*P \<* 0.001), neural invasion (*P \<* 0.001) and TNM stage (*P \<* 0.001). Compared with the small tumor volume-patients, patients with larger tumor volume were found more frequently in Borrmann type III or IV, having a higher proportion in poor differentiation, in advanced T stage and N stage, in positive vessel and neural invasion and in advanced TNM stage.

Prognostic value of V stage in gastric cancer {#s2_3}
---------------------------------------------

Prognostic predictors were identified by univariate and multivariate analysis in training set (Table [2](#T2){ref-type="table"}). Age (*P* = 0.025), tumor location (*P* = 0.004), macroscopic type (*P \<* 0.001), differentiation degree (*P \<* 0.001), tumor diameter (*P \<* 0.001), T stage (*P \<* 0.001), N stage (*P \<* 0.001), V stage (*P \<* 0.001), vessel invasion (*P \<* 0.001) and neural invasion (*P \<* 0.001) were risk factors for prognosis of gastric cancer. Multivariate analysis (Table [2](#T2){ref-type="table"}) showed that age (*P* = 0.016), macroscopic type (*P* = 0.001), N stage (*P \<* 0.001) and V stage (*P \<* 0.001) were independent prognostic factors for gastric cancer.

###### Univariate and multivariate analysis of overall survival in training set

  Characteristics              Univariate analysis   Multivariate analysis   C-index    AIC                                               
  ---------------------------- --------------------- ----------------------- ---------- ------- ---------------------- ---------- ------- --------
  Age                          0.203                 1.225 (1.026--1.464)    0.025      0.283   1.327 (1.053--1.671)   0.016      0.528   3936.8
  Gender                       0.017                 1.017 (0.818--1.265)    0.879                                                0.499   3935.5
  Tumor location               0.003                 1.003 (1.001--1.006)    0.004                                                0.516   3937.0
  Macroscopic type             0.540                 1.716 (1.566--1.879)    \< 0.001   0.257   1.292 (1.109--1.507)   0.001      0.653   3832.8
  **Differentiation degree**   0.422                 1.525 (1.352--1.720)    \< 0.001                                             0.593   3894.7
  Tumor diameter               0.632                 1.882 (1.721--2.058)    \< 0.001                                             0.686   3835.3
  T stage                      0.736                 2.087 (1.889--2.306)    \<0.001                                              0.681   3780.3
  N stage                      0.657                 1.930 (1.798--2.072)    \< 0.001   0.561   1.753 (1.576--1.949)   \< 0.001   0.736   3698.2
  V stage                      0.681                 1.975 (1.820--2.144)    \< 0.001   0.340   1.405 (1.235--1.599)   \< 0.001   0.715   3768.2
  Vessel invasion              1.087                 2.966 (2.282--3.855)    \< 0.001                                             0.614   3871.8
  Neural invasion              1.237                 3.445 (2.395--4.955)    \< 0.001                                             0.579   3880.2

HR: Hazard ratio; CI: Confidence interval.

The prognostic value of V stage was also analyzed in validation set using the cutoff points from training set (Table [3](#T3){ref-type="table"}). V stage was still the independent prognostic factor for gastric cancer in validation set (*P* = 0.045).

###### Univariate and multivariate analysis of overall survival in validation set

  Characteristics              Univariate analysis   Multivariate analysis   C-index    AIC                                              
  ---------------------------- --------------------- ----------------------- ---------- ------- ---------------------- --------- ------- --------
  Age                          0.355                 1.426 (1.193--1.705)    \< 0.001   0.312   1.366 (1.093--1.707)   0.006     0.512   4137.4
  Gender                       0.128                 1.136 (0.922--1.399)    0.230                                               0.546   4146.5
  Tumor location               0.005                 1.005 (1.003--1.008)    \< 0.001                                            0.495   4146.4
  Macroscopic type             0.587                 1.798 (1.629--1.984)    \< 0.001   0.174   1.190 (1.018--1.391)   0.029     0.657   4032.1
  **Differentiation degree**   0.473                 1.606 (1.417--1.819)    \< 0.001                                            0.591   4112.3
  Tumor diameter               0.519                 1.681 (1.541--1.833)    \< 0.001                                            0.656   4039.4
  T stage                      0.752                 2.121 (1.906--2.359)    \< 0.001   0.332   1.394 (1.071--1.815)   0.014     0.686   3979.3
  N stage                      0.637                 1.891 (1.762--2.029)    \< 0.001   0.485   1.625 (1.471--1.795)   \<0.001   0.728   3919.9
  V stage                      0.646                 1.907 (1.752--2.076)    \< 0.001   0.200   1.221 (1.004--1.486)   0.045     0.701   3962.4
  Vessel invasion              1.173                 3.230 (2.490--4.190)    \< 0.001                                            0.627   4062.3
  Neural invasion              1.214                 3.366 (2.318--4.887)    \< 0.001                                            0.574   4095.7

HR: Hazard ratio; CI: Confidence interval.

Comparison of predictive value of V and VNM stage {#s2_4}
-------------------------------------------------

C-index and AIC were calculated in order to assess the predictive accuracy and prognostic discriminatory ability of each factor for prognosis of gastric cancer in training set (Table [2](#T2){ref-type="table"}). A larger C-index and smaller AIC value of V stage were found when compared with tumor diameter (C-index: 0.715 vs 0.686; AIC: 3768.2 vs 3835.3, *P \<* 0.001) and T stage (C-index: 0.715 vs 0.681; AIC: 3768.2 vs 3780.3, *P \<* 0.001) (Figure [2A](#F2){ref-type="fig"}). VNM stage also revealed significant superiority to TNM stage in predictive accuracy and prognostic discriminatory ability (C-index: 0.756 vs 0.743; AIC: 3667.2 vs 3668.8, *P \<* 0.001) (Figure [2C](#F2){ref-type="fig"}).

![Comparison of predictive value\
(**A**) Comparison among tumor diameter, T stage and V stage in training set; (**B**) Comparison among tumor diameter, T stage and V stage in validation set; (**C**) Comparison between TNM and VNM stage in training set; (**D**) Comparison between TNM and VNM stage in validation set.](oncotarget-08-18968-g002){#F2}

In validation set, the predictive accuracy and prognostic discriminatory ability of V stage and VNM stage were still better than that of tumor diameter, T stage (Table [3](#T3){ref-type="table"}, Figure [2B](#F2){ref-type="fig"}) and TNM stage (Figure [2D](#F2){ref-type="fig"}) respectively.

Multivariable models and nomograms {#s2_5}
----------------------------------

Two multivariable prediction models were built in training set. TNM model was based on the selection of age, gender, tumor location, macroscopic type, differentiation degree, T stage, N stage, vessel invasion and neural invasion. VNM model was based on the selection of age, gender, tumor location, macroscopic type, differentiation degree, N stage, V stage, vessel invasion and neural invasion. Finally, results of the two multivariable regression models were showed in Table [4](#T4){ref-type="table"}. Consistent with the results of multivariate analysis above, V stage was still selected as an independent prognostic factor in VNM model.

###### Multivariable models for predicting overall survival in training set

  Characteristics              TNM model   VNM model                                                         
  ---------------------------- ----------- ---------------------- ---------- -------- ---------------------- ----------
  Age                          0.307       1.359 (1.080--1.711)   0.009      0.288    1.334 (1.059--1.680)   0.015
  Macroscopic type             0.269       1.309 (1.121--1.529)   0.001      0.253    1.288 (1.103--1.503)   0.001
  **Differentiation degree**   0.166       1.181 (0.966--1.443)   0.105      0.198    1.219 (1.000--1.487)   0.005
  T stage                      0.412       1.510 (1.269--1.798)   \< 0.001   ---      ---                    ---
  N stage                      0.562       1.754 (1.575--1.954)   \< 0.001   0.541    1.719 (1.543--1.913)   \< 0.001
  V stage                      ---         ---                    ---        0.331    1.392 (1.223--1.585)   \< 0.001
  C-index                      0.767                                         0.775                           
  AIC                          3648.7                                        3635.6                          

C-index: Harrell\'s concordance index; AIC: Akaike Information Criterion;

HR: Hazard ratio; CI: Confidence interval.

Two nomograms were developed for predicting overall survival in training set (Figure [3A](#F3){ref-type="fig"} and [3C](#F3){ref-type="fig"}). The VNM model showed significant advantages than TNM model in predictive accuracy and prognostic discriminatory ability (C-index: 0.775 vs 0.767; AIC: 3635.6 vs 3648.7, *P \<* 0.001) (Table [4](#T4){ref-type="table"}). The calibration curves of the two models both showed good agreement between predicted and actual outcomes (Figure [3B and 3D](#F3){ref-type="fig"}).

![Nomograms in training set\
(**A**) and (**B**) Nomogram plots and calibration curves of TNM stage; (**C**) and (**D**) Nomogram plots and calibration curves of VNM stage.](oncotarget-08-18968-g003){#F3}

The results in validation set were consistent with those in training set. The predictive accuracy and prognostic discriminatory ability of VNM model were significant better than those of TNM model (Table [5](#T5){ref-type="table"}). The predicted survival of the two models showed good agreement with observed survival (Figure [4](#F4){ref-type="fig"}).

![Nomograms in validation set\
(**A**) and (**B**) Nomogram plots and calibration curves of TNM stage; (**C**) and (**D**) Nomogram plots and calibration curves of VNM stage.](oncotarget-08-18968-g004){#F4}

###### Multivariable models for predicting overall survival in validation set

  Characteristics    TNM model   VNM model                                                         
  ------------------ ----------- ---------------------- ---------- -------- ---------------------- ----------
  Age                0.358       1.430 (1.144--1.787)   0.002      0.322    1.380 (1.104--1.726)   0.005
  Macroscopic type   0.201       1.223 (1.048--1.427)   0.011      −0.193   1.213 (1.040--1.415)   0.014
  Vessel invasion    0.244       1.227 (0.951--1.714)   0.105      0.320    1.378 (1.029--1.844)   0.031
  T stage            0.505       1.657 (1.380--1.990)   \< 0.001   ---      ---                    ---
  N stage            0.475       1.607 (1.447--1.785)   \< 0.001   0.442    1.556 (1.400--1.730)   \< 0.001
  V stage            ---         ---                    ---        0.379    1.461 (1.276--1.672)   \< 0.001
  C-index            0.767                                         0.769                           
  AIC                3848.6                                        3848.4                          

C-index: Harrell\'s concordance index; AIC: Akaike Information Criterion;

HR: Hazard ratio; CI: Confidence interval.

Comparison of formulas {#s2_6}
----------------------

In order to evaluate the superiority of the current volume calculating formula, we further validated the formula reported in the previous study using our center\'s data (Table [6](#T6){ref-type="table"}). The results showed that the V stage, VNM stage and the multivariable model calculated by current formula had a larger C-index and a smaller AIC value than those calculated by the previous formula (all *P \<* 0.001).

###### Comparison and validation between the two formulas

                        Current formula   Previous formula   *P* value            
  --------------------- ----------------- ------------------ ----------- -------- ----------
  Training group                                                                  
  V stage               0.715             3768.2             0.693       3845.4   \< 0.001
  VNM stage             0.756             3667.2             0.732       3753.3   \< 0.001
  Multivariable model   0.775             3635.6             0.764       3712.6   \< 0.001
  Validation group                                                                
  V stage               0.701             3962.4             0.684       3993.3   \< 0.001
  VNM stage             0.746             3862.9             0.723       3917.5   \< 0.001
  Multivariable model   0.769             3848.4             0.756       3908.2   \< 0.001

Current formula: V = Tumor diameter × (T stage)^2^/2;

Previous formula \[[@R33]\]: V = pT × (tumor size/2)^2^.

DISCUSSION {#s3}
==========

The current study investigated the prognostic value of tumor volume for gastric cancer. The results showed that the predictive value of V stage for gastric cancer was superior to tumor diameter and T stage. VNM staging system could significantly improve the predictive accuracy and prognostic discriminatory ability for gastric cancer.

The actual malignancy of gastric cancer is complex due to the variety of appearances and patterns of invasion \[[@R17]\]. Up to now, T stage and N stage were demonstrated to be the most significant prognostic factors for gastric cancer in several previous studies \[[@R18]--[@R20]\]. Tumor diameter, which has been considered as a rough indicator of tumor size for gastric cancer \[[@R21], [@R22]\], was closely related with histologic type, lymph node metastasis, tumor invasion, vessel invasion, neural invasion and peritoneal metastasis \[[@R23]--[@R25]\]. Further investigations demonstrated that tumor diameter was an independent prognostic factor for gastric cancer \[[@R26]--[@R28]\]. Saito et al. \[[@R28]\] found that tumor diameter could also be used to predict the recurrence site of gastric cancer. Moreover, Deng et al. \[[@R29]\] demonstrated that tumor diameter represented better prognostic stratification ability compared with T stage, while Zhao et al. \[[@R16]\] reported that the prognostic prediction value was comparable between the two variables. In both studies above, they replaced T stage with tumor diameter in the TNM staging system and found that the new classification was more competent in predicting the prognosis of gastric cancer than the current TNM staging system.

However, tumor diameter or T stage alone could not accurately reflect the actual tumor burden of gastric cancer due to this cancer\'s complicated morphology and inconsistent pattern of invasion \[[@R2], [@R17], [@R27], [@R28]\]. Thus, a new index which could better reflect the actual size of this tumor is needed.

Tumor volume, which could accurately reflect the tumor burden, may possess significant prognostic value for gastric cancer. Moreover, tumor volume was reported as an independent prognostic factor in several cancers, such as non-small-cell lung carcinoma \[[@R30]\], nasopharyngeal carcinoma \[[@R31]\] and malignant melanoma \[[@R32]\]. However, study assessing the predictive value of tumor volume for gastric cancer is lacking. Up to date, there is only one study reported by Jiang et al \[[@R33]\] that calculated tumor volume via the formula V = pT × (tumor size/2)^2^ demonstrated tumor volume maybe more reliable than T stage in predicting prognosis of gastric cancer in a cohort of 497 patients. Further, they conducted a VNM staging system by replacing the T stage with tumor volume and found that it was more appropriate than the current TNM staging system in predicting prognosis of gastric cancer patients.

In current study, we calculated the tumor volume based on the formula V = Tumor diameter × T stage^2^/2. The mathematic model of tumor volume referred to the formula V = length × width^2^/2 in the tumor bearing mouse model \[[@R34]\]. We used tumor diameter instead of the length and replaced the width with T stage. We first used the C-index and AIC value to evaluate the predictive accuracy and prognostic discriminatory ability for tumor volume, respectively. The predictive value of V stage was higher than tumor diameter and T stage. However, accurate prediction of prognosis is more determined by the staging system than a variable alone \[[@R12]\]. We then conducted the VNM stage on the basis of the two most powerful prognostic predictors---V stage and N stage. The predictive accuracy and prognostic discriminatory ability of VNM stage was better than those of TNM stage.

Further, two nomograms were developed for predicting the overall survival. The VNM model had significant advantages in the predictive accuracy and prognostic discriminatory ability than TNM model. The predicted survival of VNM model showed well agreement with the actual survival.

A good staging system, which could not only be able to predict survival, but also guide the adjuvant therapy, is of great importance for patients with gastric cancer \[[@R35]\]. The predictive superiority of tumor volume demonstrated in current study was consistent with Jiang\'s findings \[[@R33]\]. To show the improvement we got in this study, we then validated their formula using our data and found that the tumor volume calculated by our formula V = Tumor diameter × T stage2/2 revealed better predictive accuracy and prognostic discriminatory ability.

There are also some limitations in our present study. First, it was a retrospective study of a single center\'s experiences. Multi-center studies are needed to verify the predictive value of tumor volume. Second, the calculation of tumor volume is not simple and immediate. Thus, a more convenient and accurate index which could reflect the tumor burden is needed.

MATERIALS AND METHODS {#s4}
=====================

From September 2008 to March 2015, a total of 3409 gastric cancer patients who received radical gastrectomy in our department were retrospectively analyzed. The inclusion criteria were listed as follows: 1) without neoadjuvant chemotherapy; 2) without multiple stomach tumors or distant metastasis; 3) with complete follow-up records. This study was approved by the Ethics Committee of Xijing Hospital, and written informed consent was obtained from all patients before surgery.

All of the patients received radical gastrectomy according to the recommendation of Japanese Gastric Cancer Treatment Guidelines \[[@R11]\]. The patients were followed up till November 2015 by enhanced chest and abdominal CT and gastroscopy every 3 months.

Clinicopathological data including age, gender, tumor location, macroscopic type, tumor diameter, differentiation degree, T stage, N stage, vessel invasion, neural invasion and TNM stage were recorded. Tumor diameter was measured and defined as the maximum diameter of the tumor according to the Japanese classification of gastric carcinoma: 3rd English edition \[[@R36]\]. The TNM stage were defined on the basis of 7th edition of AJCC cancer staging manual \[[@R10]\].

Data were processed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, USA). With the X-tile software (Yale University) \[[@R37]\], the 3409 patients were randomly divided into training set and validation set according to sample size ratio of 1:1. The optimal cut-off values of tumor volume were calculated using X-tile software (Supplementary). Discrete variables were analyzed using the Chi-square test or Fisher\'s exact test. Risk factors for survival were identified by univariate analysis and Cox\'s proportional hazards regression model was employed for multivariate analysis. Overall survival was analyzed by the Kaplan-Meier method and differences between curves were compared using log-rank test. A backward procedure based on the Akaike information criterion (AIC) was used for multivariable selection. Nomogram and calibration curve were displayed using the package of Regression Modeling Strategies (<http://CRAN.R-project.org/package=rms>) in R (version3.1.2, <http://www.R-project.org/>). AIC and concordance index (C-index) values within a cox proportional hazard regression model were calculated in order to compare the prognostic discriminatory ability and predictive accuracy of variables using the package of Harrell Miscellanceous (<http://CRAN.R-project.org/package=Hmisc>.). A smaller AIC value indicated a better discriminatory ability \[[@R38]\], whereas a larger C-index represented a more predictive accuracy \[[@R39]\]. The likelihood ratio χ2 test was used to compare the different C-indexes between different models. The two-tail *P value* was considered to be statistically significant at the 5% level.

CONCLUSIONS {#s5}
===========

Tumor volume was significantly associated with clinicopathological features and prognosis of gastric cancer. The predictive value of tumor volume was higher than tumor diameter and T stage. In comparison with TNM staging system, VNM staging system could improve the predictive accuracy and prognostic discriminatory ability for gastric cancer.
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